Compared with the proneural (PN) GBMs and low-grade gliomas, mesenchymal (MES) GBMs have elevated TAZ expression due to the lower methylation level in its promoter region (Bhat et al., 2011). Here, WWTR1 is linked to central nervous system cancer.